Finally, an in-person meeting of the international research team arrived. The venue was a historic European city with a rich academic atmosphere, where ancient architecture blended with the modern atmosphere of scientific research. My daughter, leading the Chinese team, entered the solemn and awe-inspiring conference hall, carrying carefully prepared presentations of their latest research findings.
Inside the conference hall, medical elites from around the world, dressed in formal attire, whispered about cutting-edge ideas, or intently flipped through academic materials. The air was thick with tension and excitement. My daughter took a deep breath and walked steadily to the podium. The spotlight instantly shone on her, illuminating her confident and resolute face. She gently cleared her throat, and her sonorous, fluent English echoed throughout the hall.
On the large screen, high-definition experimental images flashed one by one, accompanied by detailed data charts, showcasing the Chinese team's months of research efforts. From the innovative experimental design concept to the arduous experimental process to the exciting initial results, every detail was explained in a clear, accessible and detailed manner. The experts in the audience, who had been whispering to each other, were now deeply captivated by my daughter's presentation. They fell silent, their eyes fixed on the large screen, jotting down key points in their notebooks and occasionally nodding in approval of the Chinese team's outstanding achievements.
After the speech, there was a brief silence in the room, followed by thunderous applause. My daughter bowed slightly in thanks, her face beaming with pride and satisfaction. However, she knew the real challenge was just beginning—the question-and-answer session would begin.
A white-haired expert in the front row, renowned internationally in the medical field, rose first. His gaze was piercing, his voice steady and forceful. "Your team has made remarkable progress in gene-targeted therapy, which is admirable. However, I've noticed that some patients in the clinical trials experienced mild immune rejection reactions. Do you have any further optimization strategies for this? This is crucial for subsequent large-scale application."
My daughter was prepared. She nodded slightly and responded with a smile, "Thank you very much for your insightful question. Indeed, immune rejection is a major challenge in gene-targeted therapy. After discovering this phenomenon, our team immediately launched in-depth research. On the one hand, we use single-cell sequencing technology to accurately locate the immune cell subpopulations that trigger immune rejection, and then develop targeted immunomodulatory small molecule drugs, aiming to accurately inhibit overactive immune responses without affecting the body's normal immune defense function. On the other hand, we are exploring the best combination of immunosuppressants. By optimizing drug combinations and dosages, we can minimize the risk of immune rejection while ensuring that the treatment effect is not compromised. At present, these optimization strategies have shown initial success in small-scale clinical trials, and we will continue to collect data and further improve the plan."
My daughter's clear, professional, and detailed answers satisfied the expert who asked the question and sat down. Several more experts followed, asking questions covering topics such as drug development, clinical trial design, and long-term efficacy evaluation. Drawing on her solid professional knowledge, extensive practical experience, and the team's thorough preparation, my daughter calmly addressed each one, providing convincing answers. Each Q&A session was like a masterful duel, a clash of minds that not only showcased the Chinese team's scientific research prowess but also injected new vitality and wisdom into the entire international collaboration project.
As the final question was answered, the audience erupted in prolonged applause. Many international experts gathered around after the meeting, their eyes filled with admiration and a desire for collaboration. One expert from a leading American medical institution enthusiastically shook my daughter's hand and said, "Your research is truly remarkable! Our team possesses unique technologies and resources in related fields, and we sincerely hope to collaborate with you to advance this research towards clinical application." Other experts expressed similar interest, with some suggesting a joint multinational, multicenter clinical trial to expand the sample size and accelerate the research process; others offering to share the latest scientific research equipment and technology platforms to help the Chinese team overcome technical bottlenecks; and still others hoping to jointly apply for international research funding to provide stronger financial support for the project.
My daughter was filled with excitement and gratitude. She understood the significance of these collaboration proposals for conquering difficult diseases and advancing global medical progress. She enthusiastically engaged with each expert, meticulously documenting their suggestions and contact information, already envisioning a grander vision for international collaboration. This conference not only allowed my daughter to establish herself on the international medical stage but also gave her a profound understanding of the immense power of international collaboration. She firmly believed that with the collaborative efforts of the world's top medical teams, the haze shrouding difficult diseases would eventually dissipate, bringing hope and hope to countless patients and allowing the brilliance of medicine to illuminate every corner of the world.
In the days that followed, my daughter returned to China, filled with both accomplishments and anticipation. She quickly convened an emergency meeting with her team members, sharing what she had learned and observed, and relaying the valuable advice and collaboration proposals from the international experts. The team members were thrilled and filled with confidence for future research. Immediately, my daughter replanned the project schedule and division of labor based on the new collaboration proposals. She selected key members of the team and directed them to connect with international partners, beginning the preliminary preparations for a series of cross-border collaborative projects.
During the preparations for the collaboration with the US team, my daughter assigned a researcher proficient in molecular biology to discuss the technical details of gene editing and jointly design and optimize the next generation of gene-targeted therapy. Through frequent online meetings, the two repeatedly discussed the technical approach. Combining the strengths of both parties, they initially developed a new experimental plan that is expected to significantly improve treatment precision. At the same time, experienced clinical doctors were assigned to liaise with the European team on clinical trial collaborations, jointly developing standard operating procedures for the multinational, multicenter clinical trial to ensure comparability and reliability of trial data from different countries and regions.
To better integrate international resources, my daughter actively sought support from domestic scientific research authorities, securing preferential policies and financial assistance to build smoother communication bridges and solid logistical support for international collaborative projects. Thanks to the combined efforts of all parties, international collaborative projects have been likened to high-speed engines, rapidly advancing toward the ultimate goal of conquering difficult diseases. My daughter and her team members, riding this magnificent wave of international medical collaboration, continue to grow and forge ahead, writing a magnificent chapter in Chinese medical research and contributing a continuous stream of Eastern wisdom and strength to global medical development.
Continue read on readnovelmtl.com
